These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 29049220

  • 1. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M, Zhao F, Zou X, Jin S, Xiong S.
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D, Wu Y, Pu X, Chen H, Luo S, Li B, Ding C, Huang GL, He Z.
    PLoS One; 2014 Oct; 9(11):e113299. PubMed ID: 25409185
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B, Cao L, Yang P, Zhou Y, Wu XT.
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [Abstract] [Full Text] [Related]

  • 4. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y, Zeng X, Lu H, Ji H, Zhao E, Li Y.
    Oncotarget; 2016 Oct 04; 7(40):66109-66118. PubMed ID: 27623072
    [Abstract] [Full Text] [Related]

  • 5. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.
    Yang Y, Wang F, Shi C, Zou Y, Qin H, Ma Y.
    PLoS One; 2012 Oct 04; 7(5):e36813. PubMed ID: 22606291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: a meta-analysis.
    Yang J, Zhang G, Chen J.
    Clin Res Hepatol Gastroenterol; 2012 Apr 04; 36(2):169-77. PubMed ID: 22322158
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
    Wu Y, Fu H, Zhang H, Huang H, Chen M, Zhang L, Yang H, Qin D.
    Tumour Biol; 2014 Jul 04; 35(7):6913-8. PubMed ID: 24737585
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
    Zhang LQ, Wang J, Shang JQ, Bai JL, Liu FY, Guan X, Zhou JN.
    Int J Colorectal Dis; 2011 Oct 04; 26(10):1249-55. PubMed ID: 21544737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J, Liao Q, Zhang Y, Sun S, Zhong C, Liu X.
    Tumour Biol; 2012 Oct 04; 33(5):1467-76. PubMed ID: 22528945
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C, An H, Hu M, Liu Q, Geng P, Xu J, Sun B, Liu C.
    Tumour Biol; 2013 Dec 04; 34(6):3831-7. PubMed ID: 23873109
    [Abstract] [Full Text] [Related]

  • 16. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
    Akhter N, Alzahrani FA, Dar SA, Wahid M, Sattar RSA, Hussain S, Haque S, Ansari SA, Jawed A, Mandal RK, Almalki S, Alharbi RA, Husain SA.
    J Cell Biochem; 2019 Oct 04; 120(10):16452-16466. PubMed ID: 31243808
    [Abstract] [Full Text] [Related]

  • 17. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ.
    Onco Targets Ther; 2016 Oct 04; 9():4483-9. PubMed ID: 27499641
    [Abstract] [Full Text] [Related]

  • 18. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
    Xu XM, Ni XB, Yang GL, Luo ZG, Niu YM, Shen M.
    Mol Clin Oncol; 2016 Jun 04; 4(6):1078-1084. PubMed ID: 27284448
    [Abstract] [Full Text] [Related]

  • 19. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
    Qin LY, Zhao LG, Chen X, Li P, Yang Z, Mo WN.
    Asian Pac J Cancer Prev; 2014 Jun 04; 15(8):3607-12. PubMed ID: 24870765
    [Abstract] [Full Text] [Related]

  • 20. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY, Zheng R, Guo C, Niu YM.
    Diagn Pathol; 2014 Sep 10; 9():168. PubMed ID: 25204741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.